Company Announcements

In September, Dovetail Genomics signed a comarketing agreement with Illumina for promotion of its sequencing assembly services for long-range sequencing applications leveraging Illumina technology.

Pacific Biosciences announced in September that Dovetail Genomics added Pacific Biosciences’ technology to its menu of genome assembly services. The companies also signed a comarketing agreement.

10X Genomics entered into a distribution agreement in September with SCRUM for Japan.

In September, 10X Genomics named John Pouk as CCO. He was previously with Agilent Technologies, where his roles included senior vice president, Global Sales and International Operations.

In September, Rubicon Genomics and Curio Genomics agreed to comarket their respective ThruPLEX Tag-seq Kits and bioinformatics software package.

Quantapore, a developer of a single-molecular sequencing technology using nanopores, announced in September the closing of a Series C financing round, led by China BioPharma Capital I.

In September, Active Motif entered into a technology development partnership with Swift Biosciences to deliver advancements in ChIP-Seq workflow. The combined technologies allow researchers to use as little as 10 pg of ChIP enriched material.

ReadCoor, a company launched by Harvard University’s Wyss Institute for Biologically Inspired Engineering to commercialize FISSEQ (Fluorescent In Situ Sequencing Technology), completed an oversubscribed $23 million Series A financing round in September. FISSEQ is a high-throughput spatial gene sequencing technology that simultaneously reads the sequences of thousands of RNAs and visualizes their 3-D coordinates within whole cells and tissues.

In September, Agilent Technologies and Burning Rock signed an agreement to develop cancer diagnostics in China based on the Agilent SureSelect target enrichment system. Burning Rock plans to register the kit with the China FDA.

QIAGEN announced in September a collaboration with the International Commission on Missing Persons for development and validation of complete NGS solutions as well as forensic panels for identifying missing persons using SNPs.

Product Introductions

In September, Appistry launched an end-to-end solution (from sequencing through prioritization of variants) for NGS workflows using its GenomePilot platform.

GenomeNext launched in September the Olympus platform for automated ‘omics-based analysis and interpretation, featuring a DNA (germline and somatic) analysis solution and RNA analytics, as well as the ability to integrate other ‘omics-based tools. The company also introduced the Discovery Analytics platform for performing complex discovery and genetic association studies in a matter of minutes, combining clinical assessments and sample-specific conditions.

Oxford Gene Technology introduced in September the SureSeq myPanel NGS Custom Cancer Panels for NGS, featuring gene content from key cancer types and hybridization-based capture.

In September, DNASTAR launched Lasergene 14, which includes three new applications: the GenVision Pro genome browser; the NovaDock protein-protein docking application; and NovaFold Antibody, a specific antibody structure prediction programs.

Sales/Orders of Note

In September, Bluebee announced the adoption of its cloud-based genomic analysis solutions by GATC Biotech to support large-scale services.

DNAnexus announced in September that healthcare informatics solutions provider M2Gen selected its cloud translational science platform for its Oncology Research Information Exchange Network Avatar Research Program.

In September, GenomOncology announced that Genomics England will integrate its GO Knowledge Management System for clinical reporting enablement.

In September, DNA Electronics announced the receipt of a contract from the US’s Biomedical Advanced Research and Development Authority worth up to $51.9 million to develop a sequencing platform for rapid diagnosis of antimicrobial-resistant infections and influenza.